(Q38312517)

2 September 2017

title

Selection of 2'F-modified RNA aptamers against prostate-specific antigen and their evaluation for diagnostic and therapeutic applications (English)

1 reference

2 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Peter Stockley

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ciara O' Sullivan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Ciara O' Sullivan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

D H J Bunka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

P Nadal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

language of work or name

English

0 references

publication date

17 September 2013

1 reference

Analytical and Bioanalytical Chemistry

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

405

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

9149-9157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24043377%20AND%20SRC:MED&resulttype=core&format=json

Estimates of cancer incidence and mortality in Europe in 2008.

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

In vitro selection of RNA molecules that bind specific ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

The chemical biology of aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Aptamer mediated siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Selection of RNA aptamers specific to active prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

DNA and RNA aptamers: from tools for basic research towards therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Therapeutic applications of DNA and RNA aptamers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Production and Characterization of RNA Aptamers Specific for Amyloid Fibril Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Real-time apta-PCR for 20 000-fold improvement in detection limit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Design, synthesis, and proposed active site binding analysis of monocyclic 2-azetidinone inhibitors of prostate specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Efficient and highly stereoselective synthesis of a beta-lactam inhibitor of the serine protease prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Discovery and development of anticancer aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-013-7350-Y